Test: | Mycobacterium tuberculosis DNA Amplified Direct Detection NUlirt packing list or manual NPHL Test Order Form (completed in entirety) must accompany the specimen. |
Synonym: | NAAT, Quantitative Real Time PCR, Mycobacterium tuberculosis direct (MTB) |
Method: | Cepheid GeneXpert MTB Assay to detect Mycobacterium tuberculosis (MTB) complex directly from sputum specimens. The test utilizes quantitative real time PCR technology that can be used on either acid fast bacilli (AFB) smear positive specimens or AFB smear negative specimens. |
Availability: | Monday-Friday, results same day if received in department by 0800 that day. STAT testing is not indicated and should not be performed. |
Specimen: | Early morning sputum (expectorated or induced). Source of specimen is required. |
Collection Device: | Sterile leak-proof container. Place each individual specimen in a sealed bag. Source of specimen indicated on requisition is required. |
Volume: | Submit 5-15 mL sputum specimen in a sterile leak-proof container. Place each individual specimen in a sealed bag. |
Storage/Transport: | Prior to and during shipment: Refrigerated at 2-8 °C. Shipping instructions, including specimen-handling requirements during transport: |
Unacceptable: | Bloody specimens, leaking containers, Non sputum specimen. Swabs. Specimens with food or solid particles. |
Specimen Stability: | Refrigerate at 2-8 °C. |
Reference Interval: | Negative |
Reportable Disease: | Positive results are reported to local or state health department and isolates sent to NPHL. Refer to Nebraska DHHS Title 173, Communicable Diseases. |
Comments: | The GeneXpert MTB/RIF Assay test is intended for use with sputum (induced or expectorated) specimens from patients showing signs and symptoms consistent with active pulmonary tuberculosis. GeneXpert® MTB/RIF Assay is to be used as an adjunctive test for evaluating either AFB smear positive or negative sediments prepared using NALC-NaOH digestion-decontamination. Patients who are suspected of having pulmonary TB based on clinical evaluation and who have received NO anti-tuberculous therapy, less than 3 days of such therapy, or have not received such therapy in the last 12 months may be evaluated with this test. Pre-approval needed from state or local health department. Send approval to NPHL@unmc.edu or call (402) 559-9444. |
Revised: | 1/8/2020 |